Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
17,744,500
-
Share change
-
+590,861
-
Total reported value
-
$221,990,224
-
Price per share
-
$12.55
-
Number of holders
-
90
-
Value change
-
+$4,188,445
-
Number of buys
-
35
-
Number of sells
-
67
Institutional Holders of CONCERT PHARMACEUTICALS INC - COM (CNCE) as of Q4 2018
As of 31 Dec 2018,
CONCERT PHARMACEUTICALS INC - COM (CNCE) was held by
90 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,744,500 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, BlackRock Inc., INGALLS & SNYDER LLC, BVF INC/IL, DIMENSIONAL FUND ADVISORS LP, FIRST MANHATTAN CO, MILLENNIUM MANAGEMENT LLC, Vanguard Group Inc, RTW INVESTMENTS, LP, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
90
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.